Koye Pharmaceuticals debuts at Pharma Leaders Power Brand Awards 2015, bags “Emerging Company of the Year 2015”
Koye Pharmaceuticals recognised at 8th Annual Pharma Leaders Awards for fastest growing pharma company in india in branded formulations market as the “Emerging Company of the year 2015”
Koye Pharmaceuticals, India’s fastest growing mid sized pharmaceutical company having dominant presence in the key therapeutic segments with ethical marketing network received the rare distinction at the prestigious Pharma Leaders Platform in its 2015 Annual Award Editions as “Emerging Company of the year 2015” at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015 on Wednesday, 30th December at Hotel Hilton Mumbai International Airport, Mumbai, India where more than 300 power packed business tycoons, diplomats,healthcare leaders had assembled to be part of the historic debate on “PHARMA LEADERS 2015 – BRAND INDIA WINNING”. The Award Trophy & Certificate of Excellence was presented in a glittering award ceremony to the founders of the company Mr. Preetish Toraskar and Mr. Ravindra Shenoy marked by the presence of Who’s & Who’s of the Indian Pharmaceutical Industry. Mr. Louis Banks who has often been referred to as the Godfather of Indian Jazz & the iconic music composer was the Chief Guest of the evening conferred the awards with the presence of Mr.Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders Group, asia’s most analytical news media in healthcare communications.
Speaking at the meet Mr. Preetish Toraskar , co-founder of Koye Pharma said on the Healthcare Reforms in India & Koye’s commitment as “to provide fresh impetus to present healthcare reforms, I feel, as a developing country reforms would be ongoing expectations and reality. In country like ours, health-care reforms are no different. All stakeholders in the health-care space need to do their bid to ensure that collectively we create a Healthy Nation. Public Private Partnership (PPP), would thus be one of the very important model for country like India. PPAP –Public Private & Academia Partnership is what I propose as the sustainable model for a vibrant nation like ours, and we must realize its potential, and harness it to our best. Applied Research through PPAP with Strategic planning and management by government is essential.I could see PPPs and PPAP succeeding with right structure and planning in detail, and ofcourse with right-human resource in place.
Koye is an emerging healthcare company which provides a range of relevant products to aid the Indian Physicians. Today, Koye stands firm to explore and bridge the crucial gaps in current therapies. Currently, Koye focuses on optimizing, and strengthening its Women healthcare, Respiratory care, and Ortho care portfolio with novel and quality products.Embarked on a visionary journey on October 2013, Koye has become a PAN India company covering more than 100000 (0.1 million) retail pharmacies across India, with digital-driven supply chain management, and distribution capability, at par with any large cap pharmaceutical company. In a span of two years, Koye has been successful in generating more than 1000 employment opportunities in India, and made its presence felt in the Indian pharmaceutical Industry as astrong emerging company.A strong advocate of responsible corporate citizenship, Mr. Toraskar chairs many CSR Campaigns, one of such and unique one is “Care for her”. It’s an endeavour that focuses on creating awareness about breast cancer and early screening of it, through innovative devices. Regular free breast cancer screening camps are conducted simultaneously across India. More than 10,000 (ten thousand) women across India have been screened successfully, through Care for her program.Mr. Toraskar has been a popular figure among young aspiring entrepreneurs and students, for his India vision, and creating sustainable business model for a robust economy. Whenever he finds leisure, he enjoys training young entrepreneurs, and management students.
— Pharmaleaders (@pharmaleader) January 26, 2016
Mumbai-based Koye is into essential drugs for primary specialty care with products targeting ailments such as arthritis, iron deficiency, asthma, etc. As per its website, it has over 300 sales personnel spread across the country.The firm positions its products as medicines for day-to-day well-being with brands such as Coecortt, Coekastle, Coecoral, CoeHB, etc.Koye was founded by Mr. Preetish Toraskar and Mr. Ravindra Shenoy. Toraskar has two decades of experience in the pharma sector working with firms like Cipla, Lupin, Novartis, Alkem and Mylan. In his last assignment he was head of Indian commercial operations of US drug maker Mylan.Shenoy is also a long-timer with pharma sector and in his last job was joint managing director and board member at Aurobindo Pharma Ltd. He began his career with finance department and over the years managed business operations and has also spearheaded M&As. In the past he was COO of Alkem.Sequoia, one of the more active VC firms in the country, has backed around a dozen firms in the healthcare domain including Koye. The bulk of these is in healthcare delivery or services space. Product and pharma companies that it has backed include Celon Labs and Paras Pharma, a maker of FMCG and OTC healthcare products, which was sold to Reckitt Benckiser in 2011. Sequoia Capital raised $530 million in its fourth India-focused fund last year to build on its venture and early growth investment activity in India. This new fund will invest in sectors like technology, consumer and healthcare. It was the most active VC fund in the country in 2014.
The Winning Duo
Mr. Preetish Toraskar on his current role serves as the Director and one of the founding members of Koye Pharmaceuticals Pvt. Ltd. He spearheadsCorporate&Business Strategy, and Human Resources. Under his vision and leadership, Koye has attained a substantial growth in last two years from point Zero to a 1000 (one thousand) strong team across India.
Mr. Ravindra Y. Shenoy served as Joint Managing Director at Aurobindo Pharma Ltd. from June 01, 2012 to November 9, 2012. Mr. Shenoy has more than 19 years of experience in the Pharma sector spanning both domestic and international businesses. He began his career with responsibility of finance and over the years, the span of responsibilities increased to controlling business operations as Head of Business Finance, Head of Mergers & Acquisitions and Investor Relations. Prior to joining Aurobindo Pharma, Mr. Shenoy served as the Chief Operating Officer of Alkem Laboratories Limited. Mr. Shenoy serves as a Director of Arth Welfare Foundation and Enzene Biosciences Limited. He served as Director at Aurobindo Pharma Ltd. from June 01, 2012 to November 9, 2012. Mr. Shenoy is a Graduate in Commerce followed by CWA, CS, DBF, MBA of Finance (NMIMS).